Amyloid β25-35 induced ROS-burst through NADPH oxidase is sensitive to iron chelation in microglial Bv2 cells

Brain Research

Volumn 1629, Issue , 2015, Pages 282-290

  Part, Kristin ^a   Künnis Beres, Kai ^a,b   Poska, Helen ^a   Land, Tiit ^a   Shimmo, Ruth ^a   Zetterström Fernaeus, Sandra ^a  

^a TALLINN UNIVERSITY   (Estonia)

^b NATIONAL INSTITUTE OF CHEMICAL PHYSICS AND BIOPHYSICS   (Estonia)

Author keywords

A 25 35; Iron; Metal chelation; Microglia; NADPH oxidase; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); IRON; IRON CHELATING AGENT; PEPTIDE FRAGMENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MICROGLIA; MOUSE;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; IRON; IRON CHELATING AGENTS; MICE; MICROGLIA; NADPH OXIDASE; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES;

EID: 84955503055     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.09.034     Document Type: Article

References (53)

1. A.Y. Abramov, and M.R. Duchen The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides Philos. Trans. R. Soc. Lond. B.: Biol. Sci. 360 2005 2309 2314
2. S. Ayton, P. Lei, and A.I. Bush Metallostasis in Alzheimer's disease Free Radic. Biol. Med. 62 2013 76 89
3. M.L. Block NADPH oxidase as a therapeutic target in Alzheimer's disease BMC Neurosci. 9 Suppl 2 2008 S8
4. M.L. Block, L. Zecca, and J.-S. Hong Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat. Rev. Neurosci. 8 2007 57 69
5. S. Bolognin, D. Drago, L. Messori, and P. Zatta Chelation therapy for neurodegenerative diseases Med. Res. Rev. 29 2009 547 570
6. D.J. Bonda, G. Liu, P. Men, G. Perry, M.A. Smith, and X. Zhu Nanoparticle delivery of transition-metal chelators to the brain: oxidative stress will never see it coming! CNS Neurol. Disord. Drug Targets 11 2012 81 85
7. A. Budimir Metal ions, Alzheimer's disease and chelation therapy Acta Pharm. 61 2011 1 14
8. A.I. Bush, and R.E. Tanzi Therapeutics for Alzheimer's disease based on the metal hypothesis Neurotherapeutics 5 2008 421 432
9. B. Cameron, and G.E. Landreth Inflammation, microglia, and Alzheimer's disease Neurobiol. Dis. 37 2010 503 509
10. H.L. Collins, S.H.E. Kaufmann, and U.E. Schaible Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst J. Immunol. 168 2002 3458 3463
11. J.R. Connor, and S.L. Menzies Cellular management of iron in the brain J. Neurol. Sci 134 Suppl 1995 S33 S44
12. M. Deibel, W. Ehmann, and W. Markesbery Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress J. Neurol. Sci. 143 1996 137 142
13. K. Dohi, H. Ohtaki, T. Nakamachi, S. Yofu, K. Satoh, K. Miyamoto, D. Song, S. Tsunawaki, S. Shioda, and T. Aruga Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury J. Neuroinflamm. 7 2010 41
14. S. Epsztejn, O. Kakhlon, H. Glickstein, W. Breuer, and I. Cabantchik Fluorescence analysis of the labile iron pool of mammalian cells Anal. Biochem. 248 1997 31 40
15. A. Gaeta, and R.C. Hider The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy Br. J. Pharmacol. 146 2005 1041 1059
16. A. Gaeta, F. Molina-Holgado, X.L. Kong, S. Salvage, S. Fakih, P.T. Francis, R.J. Williams, and R.C. Hider Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: iron chelators with the potential for treating Alzheimer's disease Bioorg. Med. Chem. 19 2011 1285 1297
17. S. Gal, H. Zheng, M. Fridkin, and M.B.H. Youdim Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion J. Neurochem. 95 2005 79 88
18. H.-M. Gao, H. Zhou, and J.-S. Hong NADPH oxidases: novel therapeutic targets for neurodegenerative diseases Trends Pharmacol. Sci. 33 2012 295 303
19. M. a Greenough, J. Camakaris, and A.I. Bush Metal dyshomeostasis and oxidative stress in Alzheimer's disease Neurochem. Int. 62 2013 540 555
20. M.T. Heneka, and M.K. O'Banion Inflammatory processes in Alzheimer's disease J. Neuroimmunol. 184 2007 69 91
21. K. Honda, M.A. Smith, X. Zhu, D. Baus, W.C. Merrick, A.M. Tartakoff, T. Hattier, P.L. Harris, S.L. Siedlak, H. Fujioka, Q. Liu, P.I. Moreira, F.P. Miller, A. Nunomura, S. Shimohama, and G. Perry Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron J. Biol. Chem. 280 2005 20978 20986
22. K.P. Hoyes, and J.B. Porter Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools Br. J. Haematol. 85 1993 393 400
23. L.L. Iversen, R.J. Mortishire-Smith, S.J. Pollack, and M.S. Shearman The toxicity in vitro of beta-amyloid protein Biochem. J. 311 1995 1 16
24. A. Jekabsone, P.K. Mander, A. Tickler, M. Sharpe, and G.C. Brown Fibrillar beta-amyloid peptide Abeta1-40 activates microglial proliferation via stimulating TNF-alpha release and H2O2 derived from NADPH oxidase: a cell culture study J. Neuroinflamm. 3 2006 24
25. D. Jiang, X. Li, R. Williams, S. Patel, L. Men, Y. Wang, and F. Zhou Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease Biochemistry 48 2009 7939 7947
26. O. Kakhlon, and Z.I. Cabantchik The labile iron pool: characterization, measurement, and participation in cellular processes(1) Free Radic. Biol. Med. 33 2002 1037 1046
27. 25-35 Exp. Neurol. 221 2010 26 37
28. V.B. Kenche, and K.J. Barnham Alzheimer's disease & metals: therapeutic opportunities Br. J. Pharmacol. 163 2011 211 219
29. T. Kubo, S. Nishimura, Y. Kumagae, and I. Kaneko In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients J. Neurosci. Res. 70 2002 474 483
30. L. Li, and B. Frei Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity Arterioscler. Thromb. Vasc. Biol. 26 2006 2638 2643
31. L. Li, and B. Frei Prolonged exposure to LPS increases iron, heme, and p22phox levels and NADPH oxidase activity in human aortic endothelial cells: inhibition by desferrioxamine Arterioscler. Thromb. Vasc. Biol. 29 2009 732 738
32. G. Liu, P. Men, G. Perry, and M.A. Smith Nanoparticle and iron chelators as a potential novel Alzheimer therapy Methods Mol. Biol. 610 2010 123 144
33. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
34. G.J. Maghzal, K.-H. Krause, R. Stocker, and V. Jaquet Detection of reactive oxygen species derived from the family of NOX NADPH oxidases Free Radic. Biol. Med. 53 2012 1903 1918
35. L. Millucci, R. Raggiaschi, D. Franceschini, G. Terstappen, and A. Santucci Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide J. Biosci. 34 2009 293 303
36. G. Papanikolaou, and K. Pantopoulos Iron metabolism and toxicity Toxicol. Appl. Pharmacol. 202 2005 199 211
37. J.B. Porter, R. Rafique, S. Srichairatanakool, B.A. Davis, F.T. Shah, T. Hair, and P. Evans Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use Ann. N. Y. Acad. Sci. 1054 2005 155 168
38. C. Pourzand, R.D. Watkin, J.E. Brown, and R.M. Tyrrell Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin Proc. Natl. Acad. Sci. USA 96 1999 6751 6756
39. D. Pramanik, and S.G. Dey Active site environment of heme-bound amyloid β peptide associated with Alzheimer's disease J. Am. Chem. Soc. 133 2011 81 87
40. E. Prus, and E. Fibach Flow cytometry measurement of the labile iron pool in human hematopoietic cells Cytometry A 73 2008 22 27
41. M.T. Quinn, and K.A. Gauss Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases J. Leukoc. Biol. 76 2004 760 781
42. K. Reis, J. Hälldin, S. Fernaeus, C. Pettersson, and T. Land NADPH oxidase inhibitor diphenyliodonium abolishes lipopolysaccharide-induced down-regulation of transferrin receptor expression in N2a and BV-2 cells J. Neurosci. Res. 84 2006 1047 1052
43. A. Salminen, J. Ojala, A. Kauppinen, K. Kaarniranta, and T. Suuronen Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors Prog. Neurobiol. 87 2009 181 194
44. D.G. Smith, R. Cappai, and K.J. Barnham The redox chemistry of the Alzheimer's disease amyloid beta peptide Biochim. Biophys. Acta 1768 2007 1976 1990
45. M. a Smith, P.L. Harris, L.M. Sayre, and G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. USA 94 1997 9866 9868
46. H. Steiner, and C. Haass Intramembrane proteolysis by presenilins Nat. Rev. Mol. Cell Biol. 1 2000 217 224
47. T. Wang, L. Qin, B. Liu, Y. Liu, B. Wilson, T.E. Eling, R. Langenbach, S. Taniura, and J.-S. Hong Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia J. Neurochem. 88 2004 939 947
48. W.-S. Wu, Y.-S. Zhao, Z.-H. Shi, S.-Y. Chang, G.-J. Nie, X.-L. Duan, S.-M. Zhao, Q. Wu, Z.-L. Yang, B.-L. Zhao, and Y.-Z. Chang Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways Antioxid. Redox Signal. 18 2013 158 169
49. B.A. Yankner, L.K. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 1990 279 282
50. T. Yoshida, M. Tanaka, A. Sotomatsu, and S. Hirai Activated microglia cause superoxide-mediated release of iron from ferritin Neurosci. Lett. 190 1995 21 24
51. M.B.H. Youdim Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline Exp. Neurobiol 22 2013 1 10
52. L. Yu, M.T. Quinn, a R. Cross, and M.C. Dinauer Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase Proc. Natl. Acad. Sci. USA 95 1998 7993 7998
53. L. Yu, L. Zhen, and M.C. Dinauer Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits J. Biol. Chem. 272 1997 27288 27294